Financial results - DR. REDDYS LABORATORIES ROMANIA SRL

Financial Summary - Dr. Reddys Laboratories Romania Srl
Unique identification code: 27144903
Registration number: J2010006590401
Nace: 4646
Sales - Ron
44.488.207
Net Profit - Ron
3.517.975
Employees
107
Open Account
Company Dr. Reddys Laboratories Romania Srl with Fiscal Code 27144903 recorded a turnover of 2024 of 44.488.207, with a net profit of 3.517.975 and having an average number of employees of 107. The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Dr. Reddys Laboratories Romania Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 5.207.923 5.702.469 6.238.838 7.586.976 7.965.875 26.138.240 36.752.825 47.986.005 46.463.878 44.488.207
Total Income - EUR 5.217.914 5.715.787 6.242.107 7.597.305 7.966.858 27.215.997 37.219.191 48.016.628 46.496.647 46.072.865
Total Expenses - EUR 4.696.528 5.089.404 5.636.055 6.774.527 7.103.901 25.757.060 34.571.266 44.390.953 42.716.418 41.844.926
Gross Profit/Loss - EUR 521.387 626.382 606.052 822.778 862.957 1.458.937 2.647.925 3.625.676 3.780.229 4.227.938
Net Profit/Loss - EUR 381.200 489.617 460.165 626.379 670.199 1.211.376 2.178.413 3.018.075 3.129.840 3.517.975
Employees 78 81 80 78 78 83 0 95 97 107
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -3.7%, from 46.463.878 euro in the year 2023, to 44.488.207 euro in 2024. The Net Profit increased by 405.626 euro, from 3.129.840 euro in 2023, to 3.517.975 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Dr. Reddys Laboratories Romania Srl

Rating financiar

Financial Rating -
DR. REDDYS LABORATORIES ROMANIA...

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Dr. Reddys Laboratories Romania...

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Dr. Reddys Laboratories Romania...

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Dr. Reddys Laboratories Romania...

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Dr. Reddys Laboratories Romania Srl - CUI 27144903

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 38.030 40.965 49.430 57.628 53.185 94.704 102.504 269.720 460.423 433.721
Current Assets 2.333.816 2.801.464 3.672.323 4.393.850 4.678.135 20.240.146 22.289.458 34.924.047 34.007.095 35.544.096
Inventories 42.587 0 30.130 18.790 9.288 7.408.021 3.856.550 12.313.545 12.818.026 11.494.636
Receivables 1.522.367 2.378.747 3.247.618 4.005.258 4.471.433 11.827.112 17.108.611 20.813.222 19.404.148 22.699.427
Cash 768.862 422.717 394.575 369.802 197.413 1.005.013 1.324.298 1.797.281 1.784.921 1.350.033
Shareholders Funds 2.108.508 2.576.621 2.993.185 3.564.634 4.165.800 5.298.202 7.359.122 10.400.029 13.498.332 16.940.868
Social Capital 382.452 378.552 372.146 365.316 358.242 351.450 343.657 344.723 343.677 341.757
Debts 115.062 169.293 511.203 645.147 359.970 14.763.560 14.614.754 24.574.219 20.506.073 18.553.622
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4646 - 4646"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 35.544.096 euro in 2024 which includes Inventories of 11.494.636 euro, Receivables of 22.699.427 euro and cash availability of 1.350.033 euro.
The company's Equity was valued at 16.940.868 euro, while total Liabilities amounted to 18.553.622 euro. Equity increased by 3.517.975 euro, from 13.498.332 euro in 2023, to 16.940.868 in 2024.

Risk Reports Prices

Reviews - Dr. Reddys Laboratories Romania Srl

Comments - Dr. Reddys Laboratories Romania Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.